Paper Details

  1. Home
  2. Paper Details

Weekly epoetin alfa treatment of anemia in patients with cancer not undergoing therapy.

Author: ShashaDaniel, WilliamsDenise

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Epoetin alfa is a well-established treatment for anemia in cancer patients receiving chemotherapy. This study investigated the efficacy of epoetin alfa in anemic cancer patients not undergoing chemotherapy or radiation therapy. Nearly all patients achieved a minor hematologic response, and most achieved a major response. Epoetin alfa was well-tolerated and safe. These findings suggest that epoetin alfa may be a beneficial treatment for anemia in this patient population.
Paper Details　
Original Abstract of the Article :
Epoetin alfa is an established treatment of anemia in patients with cancer who are receiving chemotherapy with or without radiation therapy. However, fewer data support its use in patients with cancer not currently receiving either therapy. This 16-week, open-label, nonrandomized, multicenter pilot ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/16553139

データ提供：米国国立医学図書館（NLM）

Epoetin Alfa Treatment: Navigating the Desert of Anemia in Cancer Patients

Anemia in cancer patients can feel like a vast desert, with fatigue and weakness as the harsh conditions. This research is like a journey through this desert, exploring the use of epoetin alfa for treating anemia in cancer patients who are not undergoing chemotherapy or radiation therapy. The authors conducted a pilot study evaluating the efficacy and safety of weekly epoetin alfa treatment, seeking to provide new options for managing anemia in this population.

Epoetin Alfa Shows Promising Results for Anemia Management

This pilot study, like a wellspring of hope in the desert, suggests that epoetin alfa can be effective in treating anemia in cancer patients who are not receiving chemotherapy or radiation therapy. The results showed a significant increase in hemoglobin levels and a high response rate among the participants. The authors conclude that epoetin alfa is safe and well-tolerated, making it a potentially valuable treatment option for this patient population.

Finding Relief from Anemia in Cancer Patients

This research is a reminder that even in the most challenging situations, there is hope for improving quality of life. Epoetin alfa could offer a new avenue for managing anemia in cancer patients, helping them regain strength and vitality. It's a testament to the power of research and the ongoing search for new and effective treatments for those who are battling cancer.

Dr. Camel's Conclusion

This pilot study offers a promising glimpse into the potential of epoetin alfa as a treatment for anemia in cancer patients who are not undergoing chemotherapy or radiation therapy. The authors' findings suggest that epoetin alfa could be a safe and effective option for improving quality of life and managing anemia in this population. This research is a valuable contribution to the ongoing search for innovative therapies for cancer patients, offering a potential oasis of relief in the challenging desert of their experience.
Date :
  1. Date Completed 2006-07-11
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

16553139

DOI: Digital Object Identifier

16553139

Related Literature

Article Analysis
・Side Effects of epoetin alfa injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.